Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation

Autor: Isabelle Frey-Wagner, Gerhard Rogler, Roland H. Wenger, Pedro A. Ruiz, Kirstin Atrott, Simona Simmen, Jesus Cosin-Roger, Marianne R. Spalinger, Patrick Spielmann, Jonas Zeitz, Stephan R. Vavricka, Cheryl de Valliere, Hassan Melhem, Martin Hausmann
Přispěvatelé: University of Zurich, Ruiz, Pedro A
Jazyk: angličtina
Rok vydání: 2017
Předmět:
0301 basic medicine
General Physics and Astronomy
Pyrin domain
10052 Institute of Physiology
Mice
0302 clinical medicine
Crohn Disease
RNA
Small Interfering

Mice
Knockout

Multidisciplinary
integumentary system
TOR Serine-Threonine Kinases
Dextran Sulfate
Colitis
3100 General Physics and Astronomy
Interleukin-10
10219 Clinic for Gastroenterology and Hepatology
030220 oncology & carcinogenesis
10076 Center for Integrative Human Physiology
medicine.symptom
Science
Down-Regulation
Inflammation
610 Medicine & health
1600 General Chemistry
Biology
Article
General Biochemistry
Genetics and Molecular Biology

03 medical and health sciences
Downregulation and upregulation
1300 General Biochemistry
Genetics and Molecular Biology

NLR Family
Pyrin Domain-Containing 3 Protein

Autophagy
medicine
Animals
Humans
PI3K/AKT/mTOR pathway
RPTOR
General Chemistry
Hypoxia (medical)
medicine.disease
030104 developmental biology
Gene Expression Regulation
Immunology
Cancer research
570 Life sciences
biology
Colitis
Ulcerative
Zdroj: Nature Communications, Vol 8, Iss 1, Pp 1-13 (2017)
Nature Communications
ISSN: 2041-1723
Popis: Hypoxia regulates autophagy and nucleotide-binding oligomerization domain receptor, pyrin domain containing (NLRP)3, two innate immune mechanisms linked by mutual regulation and associated to IBD. Here we show that hypoxia ameliorates inflammation during the development of colitis by modulating autophagy and mammalian target of rapamycin (mTOR)/NLRP3 pathway. Hypoxia significantly reduces tumor necrosis factor α, interleukin (IL)-6 and NLRP3 expression, and increases the turnover of the autophagy protein p62 in colon biopsies of Crohn’s disease patients, and in samples from dextran sulfate sodium-treated mice and Il-10 −/− mice. In vitro, NF-κB signaling and NLRP3 expression are reduced through hypoxia-induced autophagy. We also identify NLRP3 as a novel binding partner of mTOR. Dimethyloxalylglycine-mediated hydroxylase inhibition ameliorates colitis in mice, downregulates NLRP3 and promotes autophagy. We suggest that hypoxia counteracts inflammation through the downregulation of the binding of mTOR and NLRP3 and activation of autophagy.
Hypoxia and HIF-1α activation are protective in mouse models of colitis, and the latter regulates autophagy. Here Cosin-Roger et al. show that hypoxia ameliorates intestinal inflammation in Crohn’s patients and murine colitis models by inhibiting mTOR/NLRP3 pathway and promoting autophagy.
Databáze: OpenAIRE